Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Craig

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 23, 2002
Systemic effect comparisons of six inhaled corticosteroid preparationsRichard J Martin, Stanley J Szefler, Vernon M Chinchilli, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2007
The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trialRichard J Martin, Stanley J Szefler, Tonya S King, et al.
The New England Journal of Medicine|June 15, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Hilary J Longhurst, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2002
Significant variability in response to inhaled corticosteroids for persistent asthmaStanley J Szefler, Richard J Martin, Tonya Sharp King, et al.
American Journal of Respiratory and Critical Care Medicine|January 6, 2007
Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthmaStephen C Lazarus, Vernon M Chinchilli, Nancy J Rollings, et al.
Lancet (London, England)|March 3, 2023
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trialTimothy J Craig, Avner Reshef, H Henry Li, et al.
Lancet (London, England)|October 27, 2004
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialElliot Israel, Vernon M Chinchilli, Jean G Ford, et al.
The New England Journal of Medicine|April 15, 2005
Daily versus as-needed corticosteroids for mild persistent asthmaHomer A Boushey, Christine A Sorkness, Tonya S King, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 21, 2010
Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameterJohn M Weiler, Sandra D Anderson, Christopher Randolph, et al.
Lancet (London, England)|November 26, 2009
Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trialMichael E Wechsler, Susan J Kunselman, Vernon M Chinchilli, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
American Journal of Respiratory and Critical Care Medicine|May 23, 2002
Systemic effect comparisons of six inhaled corticosteroid preparationsRichard J Martin, Stanley J Szefler, Vernon M Chinchilli, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2007
The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trialRichard J Martin, Stanley J Szefler, Tonya S King, et al.
The New England Journal of Medicine|June 15, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Hilary J Longhurst, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2002
Significant variability in response to inhaled corticosteroids for persistent asthmaStanley J Szefler, Richard J Martin, Tonya Sharp King, et al.
American Journal of Respiratory and Critical Care Medicine|January 6, 2007
Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthmaStephen C Lazarus, Vernon M Chinchilli, Nancy J Rollings, et al.
Lancet (London, England)|March 3, 2023
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trialTimothy J Craig, Avner Reshef, H Henry Li, et al.
Lancet (London, England)|October 27, 2004
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialElliot Israel, Vernon M Chinchilli, Jean G Ford, et al.
The New England Journal of Medicine|April 15, 2005
Daily versus as-needed corticosteroids for mild persistent asthmaHomer A Boushey, Christine A Sorkness, Tonya S King, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 21, 2010
Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameterJohn M Weiler, Sandra D Anderson, Christopher Randolph, et al.
Lancet (London, England)|November 26, 2009
Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trialMichael E Wechsler, Susan J Kunselman, Vernon M Chinchilli, et al.
Pageof 18